Here's Why Momentum in Electromed (ELMD) Should Keep going

If you are looking for stocks that are well positioned to maintain their recent uptrend, Electromed (ELMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Zacks Investment Research • Jun 19, 2026

Electromed: Strong Margins, Strong Growth, Large Runway

Electromed is rated 'buy' due to accelerating growth, margin expansion, and a large underpenetrated bronchiectasis market. ELMD benefits from a new CMS rule and a recently approved bronchiectasis drug, both driving increased disease awareness and streamlined clinician adoption. Gross margin improved to 78.5%, operating margin rose to 20.4%, and net income reached a record $3.0 million in Q3 FY 2026.

Seeking Alpha • Jun 13, 2026

Is Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes"

Electromed (ELMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research • Jun 3, 2026

New Strong Buy Stocks for June 2nd

GOLD, ELMD, TPR, PLGO and CRGY have been added to the Zacks Rank #1 (Strong Buy) List on June 2nd, 2026.

Zacks Investment Research • Jun 2, 2026

Best Momentum Stocks to Buy for June 2nd

GOLD, ELMD and TPR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 2nd, 2026.

Zacks Investment Research • Jun 2, 2026

Electromed, Inc. (ELMD) Hits Fresh High: Is There Still Room to Run?

Electromed (ELMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Investment Research • Jun 1, 2026

3 Medical Instrument Stocks Exploring GenAI to Tackle Industry Woes

GenAI is reshaping medical instruments as Electromed, Globus Medical and Intuitive Surgical navigate M&A and market pressures.

Zacks Investment Research • May 21, 2026

Electromed, Inc. (ELMD)'s Technical Outlook is Bright After Key Golden Cross

Electromed, Inc. (ELMD) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ELMD's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

Zacks Investment Research • May 19, 2026

Electromed (ELMD) is an Incredible Growth Stock: 3 Reasons Why

Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research • May 18, 2026

What Makes Electromed (ELMD) a Good Fit for 'Trend Investing'

Electromed (ELMD) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks Investment Research • May 15, 2026